- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Creator
-
Banerjee, K.
- Contributor
-
Cu, Y.
Sun, Y.
Hartog, K.
Dey, A.
Brito, L.
Verma, A.
Nandi, A.
Sarkar, P.
Valiante, NM
Geall, AJ
Barnett, SW
Otten, GR
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P312
- URN
-
urn:nbn:de:1111-2016080725323
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Banerjee, K.
- Cu, Y.
- Sun, Y.
- Hartog, K.
- Dey, A.
- Brito, L.
- Verma, A.
- Nandi, A.
- Sarkar, P.
- Valiante, NM
- Geall, AJ
- Barnett, SW
- Otten, GR
- SpringerLink (Online service)
Other Objects (12)
Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost
Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus
Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles
Hyperglycosylated gp120 mutants elicit improved CD4-binding site directed antibodies in a heterologous prime:boost regimen
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults
Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost
Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus
Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles
Hyperglycosylated gp120 mutants elicit improved CD4-binding site directed antibodies in a heterologous prime:boost regimen
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults
Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost
Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus
Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles
Hyperglycosylated gp120 mutants elicit improved CD4-binding site directed antibodies in a heterologous prime:boost regimen